The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected women.

Other than CD4+ count, the immunologic factors that underlie the relationship of HIV/AIDS with persistent oncogenic HPV (oncHPV) and cervical cancer are not well understood. Plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) are of particular interest. pDCs have both effector and antigen presenting activity and, in HIV-positive patients, low pDC levels are associated with opportunistic infections. Tregs downregulate immune responses, and are present at high levels in HIV-positives. The current pilot study shows for the first time that low pDC and high Treg levels may be significantly associated with oncHPV persistence in both HIV-positive and HIV-negative women. Larger studies are now warranted.

[1]  A. Ferenczy,et al.  Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. , 2013, The Journal of infectious diseases.

[2]  L. Weiss,et al.  The split personality of regulatory T cells in HIV infection. , 2013, Blood.

[3]  E. Murta,et al.  Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia. , 2012, Human immunology.

[4]  J. McCune,et al.  Th17 and regulatory T cells: implications for AIDS pathogenesis , 2010, Current opinion in HIV and AIDS.

[5]  J. Palefsky,et al.  Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. , 2010, The Journal of infectious diseases.

[6]  P. Coursaget,et al.  Clinician's guide to human papillomavirus immunology: knowns and unknowns. , 2009, The Lancet. Infectious diseases.

[7]  A. Moscicki,et al.  Diminished IFN‐γ and IL‐10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3 , 2009, International journal of cancer.

[8]  S. Chiplunkar,et al.  Host immune responses to cervical cancer , 2009, Current opinion in obstetrics & gynecology.

[9]  B. Fazekas de St. Groth,et al.  Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? , 2008, AIDS.

[10]  C. Meijer,et al.  CD4+CD25hi regulatory T‐cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia , 2007, International journal of cancer.

[11]  P. Lenz,et al.  Papillomavirus virus‐like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells , 2005, European journal of immunology.

[12]  K. Anastos,et al.  Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. , 2005, Journal of the National Cancer Institute.

[13]  S. Gange,et al.  Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. , 2004, Journal of the National Cancer Institute.

[14]  Yong‐jun Liu,et al.  Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells. , 2002, Human immunology.

[15]  N. Kadowaki,et al.  Natural type I interferon-producing cells as a link between innate and adaptive immunity. , 2002, Human immunology.

[16]  J. Levy,et al.  Natural type 1 interferon producing cells in HIV infection. , 2002, Human immunology.

[17]  Yong‐jun Liu.  Uncover the mystery of plasmacytoid dendritic cell precursors or type 1 interferon producing cells by serendipity. , 2002, Human immunology.

[18]  R. Noelle,et al.  Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. , 2002, Cellular immunology.

[19]  P. Fitzgerald-Bocarsly,et al.  Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection. , 2001, AIDS.

[20]  K. Reimann,et al.  Preservation of Lymphocyte Immunophenotype and Proliferative Responses in Cryopreserved Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1-Infected Donors: Implications for Multicenter Clinical Trials , 2000, Clinical Diagnostic Laboratory Immunology.

[21]  R. Burk,et al.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems , 1997, Journal of clinical microbiology.

[22]  F. Siegal,et al.  Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. , 1986, The Journal of clinical investigation.

[23]  F. Siegal,et al.  Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity , 1986 .